US Patent Issued to Salk Institute for Biological Studies on June 2 for "Genetically encoded fluorescent-iron ferritin nanoparticle probes for detecting an intracellular target by fluorescent and electron microscopy" (California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,929, issued on June 2, was assigned to Salk Institute for Biological Studies (La Jolla, Calif.). "Genetically encoded fluorescent-iron ferri... Read More

US Patent Issued to BioNTech on June 2 for "IL2 agonists" (German Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,930, issued on June 2, was assigned to BioNTech SE (Mainz, Germany). "IL2 agonists" was invented by Ugur Sahin (Mainz, Germany), Sina Feller... Read More

US Patent Issued to Janssen Biotech on June 2 for "CALR and JAK2 T-cell receptors" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,931, issued on June 2, was assigned to Janssen Biotech Inc. (Horsham, Pa.). "CALR and JAK2 T-cell receptors" was invented by Rebecca Hanson ... Read More

US Patent Issued to UCL Business on June 2 for "Engineered regulatory T cell" (British Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,932, issued on June 2, was assigned to UCL Business Ltd (London). "Engineered regulatory T cell" was invented by Hans Stauss (London), Shary... Read More

US Patent Issued to Simcere Innovation on June 2 for "Armed dual CAR-T compositions and methods for cancer immunotherapy" (Massachusetts Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,933, issued on June 2, was assigned to Simcere Innovation Inc. (Cambridge, Mass.). "Armed dual CAR-T compositions and methods for cancer imm... Read More

US Patent Issued to King's College London on June 2 for "Proinsulin peptides for Type 1 Diabetes" (British Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,934, issued on June 2, was assigned to King's College London (Greater London, Great Britain). "Proinsulin peptides for Type 1 Diabetes" was ... Read More

US Patent Issued to ST. JUDE CHILDREN'S RESEARCH HOSPITAL on June 2 for "Chimeric GMCSF-IL18 receptor" (Dutch, American Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,936, issued on June 2, was assigned to ST. JUDE CHILDREN'S RESEARCH HOSPITAL INC. (Memphis, Tenn.). "Chimeric GMCSF-IL18 receptor" was inven... Read More

US Patent Issued to Chugai Seiyaku on June 2 for "Fc region variant" (Japanese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,937, issued on June 2, was assigned to Chugai Seiyaku K.K. (Tokyo). "Fc region variant" was invented by Futa Mimoto (Shizuoka, Japan), Hitos... Read More

US Patent Issued to Amgen on June 2 for "Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles" (Washington, California Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,938, issued on June 2, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Fc-containing molecules exhibiting predictable, consistent, and ... Read More

US Patent Issued to The Council of the Queensland Institute of Medical Research on June 2 for "Antibody to Epstein Barr virus and uses thereof" (Australian Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,939, issued on June 2, was assigned to The Council of the Queensland Institute of Medical Research (Herston, Australia). "Antibody to Epstei... Read More

• ««
• «
• 46119
• 46120
• 46121
• 46122
• 46123
• 46124
• 46125
• 46126
• 46127
• 46128
• »
• »»